Sarah Devaro
Ophthalmology · Erie, PANPI 1205322419
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Alcon at 26.9% of the total. Reporting peaked in 2024 at $2,008 and has fallen 52.8% since, to $948 in 2025.
Across 56 payments — averaging $79.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- AbbVie$813
- Glaukos Corporation$628
- Bausch & Lomb Americas Inc.$351
- Tarsus Pharmaceuticals, Inc.$152
- Johnson & Johnson Surgical Vision, Inc.$129
- plus $1K from 15 others
What the payments were for
- Food & beverage$4,465100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 15 | $1,202 |
| AbbVie | 11 | $813 |
| Glaukos Corporation | 6 | $628 |
| Bausch & Lomb Americas Inc. | 3 | $351 |
| Tarsus Pharmaceuticals, Inc. | 2 | $152 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $129 |
| Dompe US, Inc. | 2 | $123 |
| Harrow Eye, LLC | 1 | $122 |
| Axogen | 1 | $121 |
| Sun Pharmaceutical Industries Inc. | 1 | $119 |
| Regeneron Healthcare Solutions, Inc. | 1 | $114 |
| Rxsight Inc | 1 | $113 |
| Astellas Pharma US Inc | 1 | $99 |
| Carl Zeiss Meditec USA, Inc. | 1 | $96 |
| NEW World Medical,inc. | 1 | $96 |
| Novartis | 1 | $73 |
| Amgen | 1 | $28 |
| Thea Pharma Inc. | 1 | $23 |
| Ocular Therapeutix, Inc. | 1 | $23 |
| Biotissue Holdings Inc. | 1 | $23 |
| Rayner Intraocular Lenses Limited | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clareon$420
- iDose$302
- XEN GLAUCOMA TREATMENT SYSTEM$221
- Hydrus Microstent$149
- Unity$148
- NGENUITY$147
- IC-8 Apthera IOL$144
- ARGOS$129
- enVista MX60 IOL$124
- Flarex$122
- IHEEZO$122
- Verkazia$122
- Tobradex ST$122
- Natacyn$122
- OZURDEX$122
- VUITY$122
- AVANCE NERVE GRAFT$121
- CEQUA$119
- EYLEA HD$114
- RXSIGHT CONTACT LENS$113
How this compares
$4,465 in reported general payments places this provider in the 75th percentile of 920 ophthalmology providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 165 | $5,981 |
| Ketorolac Tromethamine | 114 | $1,950 |
| MoxifloxacinMoxifloxacin Hcl | 170 | $1,631 |
| Atropine Sulfate | 29 | $993 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 45 | $621 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Erie
- David AlmeidaErie$734K
- Julia HallerPhiladelphia$1.5M
- Francis MahPittsburgh$1.1M
- Brandon AyresBala Cynwyd$929K
- Carl RegilloPlymouth Meeting$721K
- Robert NoeckerPittsburgh$632K
- Beeran MeghparaPhiladelphia$496K
- Michael KlufasPlymouth Meeting$393K
- Jonathan MyersPhiladelphia$359K
- Mark BlecherPhiladelphia$357K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.